FDA Approves Clinical Trial for Possible HIV Cure

at 9:00 AM
 (T.J. Kirkpatrick/Getty Images)

The FDA has approved a clinical trial for an experimental stem cell therapy that aims to cure HIV patients. Richmond-based Sangamo Biosciences received approval to genetically modify patients' stem cells and return them to their bodies. The field of research has generated tremendous excitement since Timothy Brown, the so-called "Berlin patient," became the first person to be cured of HIV -- he received a bone marrow transplant from someone with a genetic mutation that causes HIV resistance.

Guests:

John Zaia, chair and professor in the Department of Virology at City of Hope and a principal investigator on the approved FDA clinical trials

Jeff Sheehy, HIV patient advocate on the governing board of the California Institute for Regenerative Medicine (CIRM)

Sponsored

Sponsored

Volume
KQED Live
Live Stream
Log In ToPledge-Free Stream
LATEST NEWSCAST
KQED
NPR
Live Stream information currently unavailable.
Share
LATEST NEWSCAST
KQED
NPR
KQED Live

Live Stream

Live Stream information currently unavailable.